Trust in Science, Trust in Health Care Workers, Trust in Governance.Vaccine Hesitancy - Scott Ratzan

Presenter: Scott C. Ratzan MD, MPA, MA
CUNY Graduate School of Public Health and Health Policy, ​Columbia University Mailman School of Public Health, ​Tufts University School of Medicine, United States; ​University of St Andrews, Scotland​
Lecture: Health Equity and Access to Medical Countermeasures. Trust in Science, Trust in Health Care Workers, Trust in Governance. Vaccine Hesitancy.
Presented in Session 3: "No One is Safe, until Everyone is"
Lessons Learned from the Pandemic: Redesigning Clinical Care, Research, and Public Health 2023
Subscribe to our newsletter: amededu.active...
For more information, visit: academicmedica...
Upcoming meetings: academicmedica...
Now more than two years since the pandemic began, it is critically important to understand and learn what worked and what did not and assess these measures’ health, social, and economic impact worldwide. Understanding the strengths and weaknesses of these strategies, considering country-specific approaches, is essential to improve the preparedness for future variant-induced waves of infections and new pandemics.
The COVID-19 pandemic brought innovations in public health, such as genomic surveillance, that could revolutionize the surveillance of pathogens for subsequent pandemics and epidemics. It also sparked a new wave of innovations across clinical care and research. The number of randomized clinical trials (RCTs) performed to evaluate COVID-19 therapeutics and vaccines is stunning and brought a wealth of data to inform clinical decision-making. There is an increased interest in the use of Real-World Evidence (RWE) to supplement RCT evidence and aid in clinical decision-making. Spurred by the pandemic, there is considerable innovation and growth in telemedicine. This tool was invaluable as a means of providing healthcare remotely during the lockdown, but it also highlighted equity issues for populations with limited Internet access.
This workshop aimed to build on this foundation and design long-term solutions to strengthen epidemic preparedness globally. Briefly, this program aimed to gather different stakeholders to discuss, raise awareness, synthesize knowledge on the lessons learned from the COVID-19 pandemic, and rethink clinical care and research through the exchange of scientific evidence from the COVID-19 pandemic.
The program gathered public (health) authorities, epidemiologists, economists, (clinical) scientists, clinicians, and other healthcare professionals to make knowledge available to policymakers worldwide and to design long-term and durable solutions for future pandemics, clinical care, and research.